InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: DeepDive post# 1780

Monday, 02/02/2015 12:58:12 AM

Monday, February 02, 2015 12:58:12 AM

Post# of 3836
Besides the NASH Phase 2 there are also two Phase 1b combo trials for Melanoma. And the CEO just said that they had enough money to take us well into 2016. By then we should have some efficacy info on one (or more) indications. Hopefully that will be enough to overcome the trust issues that the market currently has with our management.

Waiting to see the phase 2 format. They say they are going for multiple indications, which might be more expensive that what I thought initially.

Funding at this low level might be somewhat dilutive, albeit the share count is low now.

Let's see.
- Adi2

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News